These findings suggest that blocking of IL-36R signalling by administration of IL-36Ra and knockout of IL-36R expression in tumours results in different immune infiltrate profiles of tumours; however, both were capable of significantly reducing cellular proliferation of tumour cells. This evidence concerns the gene IL1RL2 and neoplasm.